Search results
Could This Indication Provide a Lift for Bristol Myers Squibb's Stock?
Motley Fool· 1 year agoLate last month, Bristol Myers Squibb's (NYSE: BMY) immunology drug, Sotyktu, received good news....
What You Need to Know Ahead of Bristol-Myers (BMY) Q4 Earnings
Zacks via Yahoo Finance· 4 months agoBristol-Myers Squibb Company BMY is scheduled to report fourth-quarter 2023 results on Feb 2, before...
What's in Store for Bristol-Myers (BMY) in Q3 Earnings?
Zacks via Yahoo Finance· 7 months agoBristol-Myers Squibb Company BMY is scheduled to report third-quarter 2023 results on Oct 26, before...
Bristol Myers Squibb (BMY) Q2 2023 Earnings Call Transcript
Motley Fool· 10 months agoAt this time, I'd like to turn the floor over to Tim Power, vice president of investor relations....
Bristol-Myers (BMY) Q2 Earnings, Sales Miss, '23 View Lowered
Zacks via Yahoo Finance· 10 months agoBristol-Myers' (BMY) second-quarter 2023 earnings and sales miss estimates due to generic erosion...
Bristol Myers accused of illegal tactics to keep Pomalyst monopoly in lawsuit
Reuters via AOL· 8 months agoBristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal...
Bristol-Myers (BMY) Q3 Earnings & Sales Beat, Opdivo Sales Grow
Zacks via Yahoo Finance· 7 months agoBristol-Myers' (BMY) third-quarter 2023 earnings and sales beat estimates as Opdivo and new products...
Bristol Myers (BMY) Announces Positive Updated NSCLC Data
Zacks via Yahoo Finance· 9 months agoBristol Myers' (BMY) repotrectinib shows durable efficacy benefits in patients with locally advanced...
Is This Monster Stock On Its Way to Another Multibillion-Dollar Drug?
Motley Fool· 2 years agoA promising cancer drug combo from Bristol Myers Squibb is months away from being approved in the...
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) Opdivo, in combination with chemotherapy, gains European Commission approval...